Global Yellow Fever Vaccine Market
Pharmaceuticals

Yellow Fever Vaccine Market Forecast To Reach $5.88 Billion By 2030: Key Growth Drivers And Industry Trends

Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.

#Yellow Fever Vaccine Market Size And Revenue Outlook Through 2030#_x000D_

The yellow fever vaccine market size has experienced consistent expansion in recent years. It is projected to increase from $4.74 billion in 2025 to $4.97 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 4.8%. Historically, this growth was driven by recurring yellow fever outbreaks, government immunization mandates, established vaccine efficacy, international travel requirements, and various public health initiatives._x000D_

_x000D_

The yellow fever vaccine market size is anticipated to show consistent expansion in the upcoming years, projected to reach $5.88 billion in 2030, achieving a compound annual growth rate (CAGR) of 4.3%. This growth during the forecast period is influenced by factors such as the climate-driven spread of mosquitoes, a rise in global travel, the broadening of vaccination infrastructure, increased funding for disease prevention, and enhanced outbreak preparedness. Key developments for the period encompass the expansion of routine immunization programs, an increased demand from international travelers, more government-led vaccination campaigns, the growing adoption of single-dose vaccines, and a focus on preventing endemic diseases._x000D_

_x000D_

#Get A Free Sample Report With In-Depth Market Insights:#_x000D_

https://thebusinessresearchcompany.com/sample_request?id=14706566&type=smp&name=Yellow%20Fever%20Vaccine%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR_x000D_

_x000D_

#Yellow Fever Vaccine Market Demand Drivers: What’s Powering Industry Growth?#_x000D_

The future expansion of the yellow fever vaccine market is anticipated, driven by the increasing international travel. This international travel refers to the movement of individuals across country borders for tourism, business, or personal purposes. The rise in international travel is attributed to growing global mobility, bolstered by economic recovery and the easing of post-pandemic travel restrictions. The yellow fever vaccine market supports travelers by providing mandatory or recommended immunization for entry into regions where yellow fever is endemic. For instance, in January 2024, according to the World Tourism Organization (UNWTO), a Spain-based international tourism agency, global international tourist arrivals reached 1.286 billion in 2023, up from 0.96 billion in 2022, marking an increase of 0.326 billion international tourists year-on-year. Therefore, the expansion of international travel is driving the growth of the yellow fever vaccine market._x000D_

_x000D_

#Yellow Fever Vaccine Market Segment Outlook: Which Categories Are Growing Fastest?#_x000D_

The yellow fever vaccine market covered in this report is segmented – _x000D_

_x000D_

1) By Product: Powder, Liquid _x000D_

2) By Application: Routine Immunization, Travelers, Other Applications_x000D_

3) By End-User: Hospitals, Diagnostic Centers, Point Of Care Centers, Other End Users_x000D_

_x000D_

Subsegments:_x000D_

1) By Powder: Lyophilized Powder For Reconstitution, Freeze-Dried Powder For Reconstitution _x000D_

2) By Liquid: Ready-To-Use Liquid Vaccine, Liquid Vaccine In Pre-Filled Syringes_x000D_

_x000D_

#Yellow Fever Vaccine Market Innovation Trends: What Developments Are Reshaping The Industry?#_x000D_

Companies leading the yellow fever vaccine market are increasingly dedicated to developing innovative solutions, such as T-cell adaptive booster vaccines. This focus aims to enhance long-term immunity, improve the effectiveness of vaccines, and overcome the limitations of conventional live-attenuated vaccines. T-cell adaptive booster vaccines are specifically designed to fortify the immune system by boosting T-cell responses, which enables the body to identify and combat infections more efficiently compared to traditional antibody-centric vaccines. For example, in April 2025, the All India Institute of Medical Sciences, an India-based healthcare institute, introduced Yellow Fever Vaccination to offer travelers protection against the mosquito-borne viral disease and to issue the internationally recognized vaccination certificate. This initiative seeks to improve vaccine accessibility within Telangana, thereby reducing the need for extensive travel to other authorized centers. Additionally, the program upholds international health regulations by ensuring safe administration under medical supervision, particularly for individuals with contraindications._x000D_

_x000D_

#Yellow Fever Vaccine Market Leading Companies And Competitive Benchmarking#_x000D_

Major companies operating in the yellow fever vaccine market are Sanofi S.A., Bio-Manguinhos, Institut Pasteur de Dakar, Instituto Butantan, Bio Farma, Biological E. Limited, Beijing Tiantan Biological Products Co. Ltd., Wuhan Institute of Biological Products, Merck & Co. Inc., GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Lonza Group AG, WuXi Biologics, Ology Bioservices, Valneva SE, Bavarian Nordic A/S, Panacea Biotec Ltd., Biovac, Novavax Inc., PnuVax Incorporated _x000D_

_x000D_

#View The Full Yellow Fever Vaccine Market Report:#_x000D_

https://thebusinessresearchcompany.com/report/yellow-fever-vaccine-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR_x000D_

_x000D_

#Yellow Fever Vaccine Market Largest Region: Which Geography Holds The Biggest Share?#_x000D_

North America was the largest region in the yellow fever vaccine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the yellow fever vaccine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#Reach Out To Our Team:#_x000D_

_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas: +1 310-496-7795_x000D_

Asia: +44 7882 955267 & +91 8897263534_x000D_

Europe: +44 7882 955267_x000D_

Email us at: marketing@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model